HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note ...

Silence Therapeutics (NASDAQ:SLN – Free Report) had its price objective reduced by BMO Capital Markets from $67.00 to $25.00 in a report issued on Tuesday,Benzinga reports. They currently have an ...

SLN has started construction and mobilization for a 10,000 square foot expanded terminal. Salina Airport Authority Executive ...

Maggie Spillane will assume Cowling’s role and management of a $500 million apartment and shopping center portfolio.

Credible information as to how public funds have been misappropriated from the entire Mahinda Rajapaksa official residence ...

The U.S. stock market’s sell-off cut deeper on Monday as Wall Street questioned how much pain President Donald Trump will let the economy endure through tariffs and other policies in order to get what ...

Stock indexes plunged on Monday, with the S&P 500, the Dow Jones Industrials, and the Nasdaq 100 posting 5-3/4 month lows.  Stocks sank because of concern that tariffs and cuts to the federal ...

Twenty-six. That’s how many students have died in the residential schools governed by the ST and SC Development department of ...

The President, Anura Kumara Dissanayake, said in the parliament on 28 February 2025 that the Number of persons in all three ...

SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will present a company overview at the ...

Reveleer, the leading value-based care enablement platform, today announced the launch of its next generation retrospective risk technology, designed to advance risk adjustment programs with ...